PuREC / 島根大学発バイオベンチャー

Provides a culture technology for REC (Rapidly Expanding Cells), a high-purity mesenchymal stem cell type with about 1000 times the proliferation and differentiation capacity of conventional mesenchymal stem cells, to address low efficacy and scalability in regenerative and transplant medicine for a broad range of diseases. Sells to B2B partners in healthcare and life sciences, including medical institutions, research organizations, and companies developing cell-based therapies. Positioned as a differentiated cell technology that offers higher therapeutic efficacy than standard mesenchymal stem cells through a proprietary high-purity culture method developed as a university spin-out.

Key features

• High-purity mesenchymal stem cell culture
• Rapidly Expanding Cell (REC) technology
• 1000x proliferation and differentiation capacity
• Regenerative medicine for broad diseases
• Transplant medicine application